Pranav Tripathi
Name: Pranav Tripathi
Email: pranav.biophd@mnnit.ac.in
Phone NO.: 9651683316
Qualification: PhD Thesis Submitted
Designation: Senior research Fellow
Department:Department of Biotechnology
College address: MNNIT Allahabad, Teliyarganj, Prayagraj
Postal address:Flat no. 603, Vinayak Mayo residency, Shiv Ram Das Gulati Marg, Near mayo hall chauraha, Prayagraj-211018
Award for: InSc Research Excellence Award
Publication title: Novel ssDNA Ligand Against Ovarian Cancer Biomarker CA125 With Promising Diagnostic Potential
Paper Title: Novel ssDNA Ligand Against Ovarian Cancer Biomarker CA125 With Promising Diagnostic Potential
Journal Name:Frontiers in Chemistry
Volume:8
Issue No.:400
Month of publication:May, 2020
Year:2020
ISSN: 2296-2646
About Pranav Tripathi
Mr. Pranav Tripathi is a Senior Research Fellow at Motilal Nehru National Institute of
Technology (MNNIT) Allahabad, Prayagraj, who submitted his PhD thesis in the year 2020. Hereceived his B. Tech degree in Biotechnology from Amity University Uttar Pradesh, India in 2012 and her M.Tech degree in Biotechnology from Govind Ballabh Pant Insitute of Engineering and Technology (Formerly Govind Ballabh Pant Engineering College) Pauri-Garhwal, Uttarakhand, India in 2014. He qualified National Eligibility Test (organized by CSIR New Delhi) in December 2014 (NET-JRF), National Eligibility Test (organized by ICAR, New Delhi) in December 2014 (NET) and GATE Examination (Biotechnology) in 2012 and 2013. He is currently working as a doctoral student in the Department of Biotechnology, MNNIT Allahabad since January 2015. His main research area includes point of care diagnostics, Nanobiotechnology, molecular biology, assay development, assay validation, translational biotechnology, and analytical sensors. He has been awarded ‘Carl Storm International diversity funding’ to attend GRC RNA Nanotechnology, USA in January 2019, best poster presentation in BioSangam 2018 held at MNNIT Allahabad and an 'InnoCentive award’ for his solution entitled ‘alternative to antibiotics’. His publication base comprises of 4 patents, 5 peer-reviewed publications and 3 book chapters since 2016.